Literature DB >> 19465412

Frequency and predictors for the risk of stroke recurrence up to 10 years after stroke: the South London Stroke Register.

K M Mohan1, S L Crichton, A P Grieve, A G Rudd, C D A Wolfe, P U Heuschmann.   

Abstract

BACKGROUND: Data estimating the risk of, and predictors for, long-term stroke recurrence are lacking.
METHODS: Data were collected from the population-based South London Stroke Register. Patients were followed up for a maximum of 10 years. Kaplan-Meier estimates and Cox proportional hazards models were used to assess the cumulative risk of and predictors for first stroke recurrence. Variables analysed included sociodemographic factors, stroke subtype (defined as cerebral infarction, intracerebral haemorrhage and subarachnoid haemorrhage), stroke severity markers and prior-to-stroke risk factors.
RESULTS: Between 1995 and 2004, 2874 patients with first-ever stroke were included. The mean follow-up period was 2.9 years. During 8311 person-years of follow-up, 303 recurrent events occurred. The cumulative risk of stroke recurrence at 1 year, 5 years and 10 years was 7.1%, 16.2% and 24.5% respectively. No differences in stroke recurrence were noted between the stroke subtypes. Factors increasing the risk of recurrence at 1 year were previous myocardial infarction (HR 1.73; 95% CI 1.08 to 2.78) and atrial fibrillation (HR 1.61; 95% CI 1.04 to 4.27); at 5 years, hypertension (HR 1.47; 95% CI 1.08 to 1.99) and atrial fibrillation (HR 1.79; 95% CI 1.29 to 2.49); and at 10 years, older age (p = 0.04), and hypertension (HR 1.38, 95% CI 1.04 to 1.82), myocardial infarction (HR 1.50, 95% CI 1.06 to 2.11) and atrial fibrillation (HR 1.51, 95% CI 1.09 to 2.09).
CONCLUSIONS: Very-long-term risk of stroke recurrence is substantial. Different predictors for stroke recurrence were identified throughout the follow-up period. Risk factors prior to initial stroke have a significant role in predicting stroke recurrence up to 10 years.

Entities:  

Mesh:

Year:  2009        PMID: 19465412     DOI: 10.1136/jnnp.2008.170456

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  45 in total

1.  Racial differences in recurrent ischemic stroke risk and recurrent stroke case fatality.

Authors:  Karen C Albright; Lei Huang; Justin Blackburn; George Howard; Michael Mullen; Vera Bittner; Paul Muntner; Virginia Howard
Journal:  Neurology       Date:  2018-10-03       Impact factor: 9.910

2.  Development and Validation of PREDICT-DM: A New Microsimulation Model to Project and Evaluate Complications and Treatments of Type 2 Diabetes Mellitus.

Authors:  Pooyan Kazemian; Deborah J Wexler; Naomi F Fields; Robert A Parker; Amy Zheng; Rochelle P Walensky
Journal:  Diabetes Technol Ther       Date:  2019-06       Impact factor: 6.118

3.  Recurrent Ischemic Stroke Characteristics and Assessment of Sufficiency of Secondary Stroke Prevention.

Authors:  Gülşen Kocaman; Hümeyra Dürüyen; Abdulkadir Koçer; Talip Asil
Journal:  Noro Psikiyatr Ars       Date:  2015-06-01       Impact factor: 1.339

4.  Effect of Hemodynamics on Stroke Risk in Symptomatic Atherosclerotic Vertebrobasilar Occlusive Disease.

Authors:  Sepideh Amin-Hanjani; Dilip K Pandey; Linda Rose-Finnell; Xinjian Du; DeJuran Richardson; Keith R Thulborn; Mitchell S V Elkind; Gregory J Zipfel; David S Liebeskind; Frank L Silver; Scott E Kasner; Victor A Aletich; Louis R Caplan; Colin P Derdeyn; Philip B Gorelick; Fady T Charbel
Journal:  JAMA Neurol       Date:  2016-02       Impact factor: 18.302

5.  Relevance of stroke subtype in vascular risk prediction.

Authors:  Angel Ois; Elisa Cuadrado-Godia; Ana Rodríguez-Campello; Eva Giralt-Steinhauer; Jordi Jiménez-Conde; Miguel Lopez-Cuiña; Miguel Ley; Carol Soriano; Jaume Roquer
Journal:  Neurology       Date:  2013-07-03       Impact factor: 9.910

6.  Stroke recurrence and mortality in northeastern Greece: the Evros Stroke Registry.

Authors:  Georgios Tsivgoulis; Aristeidis H Katsanos; Athanasia Patousi; Maria Pikilidou; Theodosis Birbilis; Michael Mantatzis; Maria Yavropoulou; Christina Zompola; Sokratis Triantafyllou; Nikolaos Papanas; Panagiotis Skendros; Aikaterini Terzoudi; George S Georgiadis; Pantelis Zebekakis; Efstratios Maltezos; Charitomeni Piperidou; Ioannis Heliopoulos; Konstantinos Vadikolias
Journal:  J Neurol       Date:  2018-08-20       Impact factor: 4.849

7.  Improving acute stroke management with computed tomography perfusion: a review of imaging basics and applications.

Authors:  C D d'Esterre; Enrico Fainardi; R I Aviv; T Y Lee
Journal:  Transl Stroke Res       Date:  2012-05-24       Impact factor: 6.829

8.  Cost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare setting.

Authors:  Kostas Athanasakis; Eleftheria Karampli; Dimitrios Tsounis; Aikaterini Bilitou; John Kyriopoulos
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

9.  Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland.

Authors:  James Lewsey; Pardeep S Jhund; Michelle Gillies; Jim W T Chalmers; Adam Redpath; Andrew Briggs; Matthew Walters; Peter Langhorne; Simon Capewell; John J V McMurray; Kate MacIntyre
Journal:  BMC Med       Date:  2010-04-09       Impact factor: 8.775

10.  Cost effectiveness of apixaban versus aspirin for stroke prevention in patients with non-valvular atrial fibrillation in Belgium.

Authors:  Thitima Kongnakorn; Tereza Lanitis; Annemans Lieven; Lievens Annemans; Vincent Thijs; Sophie Marbaix
Journal:  Clin Drug Investig       Date:  2014-10       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.